| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |